SFPM
BIIB icon

Sensible Financial Planning & Management’s Biogen BIIB Stock Holding History

Sensible Financial Planning & Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-89
Closed -$22K – 79
2016
Q2 		$22K Buy
+89
New +$23.5K 0.02% 49

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sensible Financial Planning & Management's BIIB Position: Q3 2016 in Review

Sensible Financial Planning & Management sold out of Biogen (BIIB) in Q3 2016, closing a stake of 89 shares — an estimated $22K sold.

Sensible Financial Planning & Management first reported a position in BIIB in Q2 2016 and held it in 1 quarter. The position peaked at $22K in Q2 2016. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

  • Sensible Financial Planning & Management reported no remaining Biogen position as of Q3 2016 after selling out during the quarter.
  • Sensible Financial Planning & Management sold 89 Biogen shares in Q3 2016, an estimated $22K.
  • Sensible Financial Planning & Management first reported a position in Biogen in Q2 2016 and held it in 1 quarter.
  • Sensible Financial Planning & Management's Biogen position peaked at $22K in Q2 2016.
  • 1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Sensible Financial Planning & Management's 13F filing for Q3 2016, filed 14 Nov 2016.